BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 19735259)

  • 1. A functional magnetic resonance imaging study of the effect of sacral neuromodulation on brain responses in women with Fowler's syndrome.
    Kavia R; Dasgupta R; Critchley H; Fowler C; Griffiths D
    BJU Int; 2010 Feb; 105(3):366-72. PubMed ID: 19735259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urodynamic study of women in urinary retention treated with sacral neuromodulation.
    DasGupta R; Fowler CJ
    J Urol; 2004 Mar; 171(3):1161-4. PubMed ID: 14767292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of occult dysautonomia in Fowler's syndrome: alteration of cardiovascular autonomic function tests in female patients presenting with urinary retention.
    Amarenco G; Raibaut P; Ismael SS; Rene-Corail P; Haab F
    BJU Int; 2006 Feb; 97(2):288-91. PubMed ID: 16430631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fowler's Syndrome-The Cause of Urinary Retention in Young Women, Often Forgotten, but Significant and Challenging to Treat.
    Szymański JK; Słabuszewska-Jóźwiak A; Jakiel G
    Int J Environ Res Public Health; 2021 Mar; 18(6):. PubMed ID: 33806865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The presence of Fowler's syndrome predicts successful long-term outcome of sacral nerve stimulation in women with urinary retention.
    De Ridder D; Ost D; Bruyninckx F
    Eur Urol; 2007 Jan; 51(1):229-33; discussion 233-4. PubMed ID: 16860462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sacral neuromodulation for neurogenic non-obstructive urinary retention in incomplete spinal cord patients: a ten-year follow-up single-centre experience.
    Lombardi G; Musco S; Celso M; Del Corso F; Del Popolo G
    Spinal Cord; 2014 Mar; 52(3):241-5. PubMed ID: 24394604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in brain activity following sacral neuromodulation for urinary retention.
    Dasgupta R; Critchley HD; Dolan RJ; Fowler CJ
    J Urol; 2005 Dec; 174(6):2268-72. PubMed ID: 16280802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging bladder sensations.
    Griffiths D
    Neurourol Urodyn; 2007 Oct; 26(6 Suppl):899-903. PubMed ID: 17654564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up of sacral neuromodulation for lower urinary tract dysfunction.
    Peeters K; Sahai A; De Ridder D; Van Der Aa F
    BJU Int; 2014 May; 113(5):789-94. PubMed ID: 24238278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sacral neuromodulation blocks pudendal inhibition of reflex bladder activity in cats: insight into the efficacy of sacral neuromodulation in Fowler's syndrome.
    Li X; Uy J; Yu M; Li S; Theisen K; Browning J; Shen B; Wang J; Roppolo JR; de Groat WC; Tai C
    Am J Physiol Regul Integr Comp Physiol; 2018 Jan; 314(1):R34-R42. PubMed ID: 28931549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fowler's Syndrome: diagnostic and therapeutic challenge].
    Bártolo M; Martins L; Martins F
    Acta Med Port; 2011; 24(4):645-8. PubMed ID: 22521026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cystomanometric study of bladder sensation during sacral neuromodulation test].
    Leclers F; Mourey E; Galas JM; Cormier L; Mangin P
    Prog Urol; 2005 Apr; 15(2):238-43. PubMed ID: 15999600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sacral neuromodulation in under- and overactive detrusor-quo vadis? : Principles and developments].
    Girtner F; Burger M; Mayr R
    Urologe A; 2019 Jun; 58(6):634-639. PubMed ID: 31139864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of urodynamic tools to guide patient selection in sacral neuromodulation.
    Drossaerts J; Rademakers K; van Koeveringe G; Van Kerrebroeck P
    World J Urol; 2015 Nov; 33(11):1889-95. PubMed ID: 25680936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sacral neuromodulation for women with Fowler's syndrome.
    Swinn MJ; Kitchen ND; Goodwin RJ; Fowler CJ
    Eur Urol; 2000 Oct; 38(4):439-43. PubMed ID: 11025383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Open-label study evaluating outpatient urethral sphincter injections of onabotulinumtoxinA to treat women with urinary retention due to a primary disorder of sphincter relaxation (Fowler's syndrome).
    Panicker JN; Seth JH; Khan S; Gonzales G; Haslam C; Kessler TM; Fowler CJ
    BJU Int; 2016 May; 117(5):809-13. PubMed ID: 26435296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravesical electrostimulation versus sacral neuromodulation for incomplete spinal cord patients suffering from neurogenic non-obstructive urinary retention.
    Lombardi G; Musco S; Celso M; Ierardi A; Nelli F; Del Corso F; Del Popolo G
    Spinal Cord; 2013 Jul; 51(7):571-8. PubMed ID: 23628893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary retention in women and sacral neuromodulation.
    Elneil S
    Int Urogynecol J; 2010 Dec; 21 Suppl 2():S475-83. PubMed ID: 20972545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing the duration of assessment of stage-1 sacral neuromodulation in nonobstructive chronic urinary retention.
    Elneil S; Abtahi B; Helal M; Digesu A; Gonzales G
    Neuromodulation; 2014 Jan; 17(1):66-70; discussion 70-1. PubMed ID: 23601054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sacral neuromodulation effects on periurethral sensation and urethral sphincter activity.
    Gleason JL; Kenton K; Greer WJ; Ramm O; Szychowski JM; Wilson T; Richter HE
    Neurourol Urodyn; 2013 Jun; 32(5):476-9. PubMed ID: 23168535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.